Skip to main content
. 2015 Jan 15;11(5):3423–3431. doi: 10.3892/mmr.2015.3205

Figure 2.

Figure 2

c-Met immunostaining and OS of subjects. OS of c-Met immunopositive cases (n=25) was significantly lower than that of c-Met immunonegative cases (n=25); log-rank test, P=0.0342. (A) Negative c-Met immunostaining. (B) Positive c-Met immunostaining. OS, overall survival.